ABOUT US
Since its establishment in the year 1987, Sangrose has grown phenomenally in being one of the largest producers of Anti leprotic API Clofazimine in the world. Sangrose is one of the leading manufacturers of soft gelatin capsules in India. The foray of Sangrose into the regulated market is through continuous development of facilities as per the latest standards. The motto of the company is “To Achieve Excellence In Bringing Out Therapeutically Effective Products”
Sangrose is today a globally recognized, pharmaceutical company with core competencies in development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms. From the very inception, Sangrose has been investing aggressively for establishing modern research and manufacturing facilities aimed at global markets, thus emerging as a world-class pharmaceutical company with in house facility covering the entire value chain from Production to marketing

Genesis
MR. C K ALEXANDER, an entrepreneur-research chemist, founded SANGROSE Laboratories in 1987. The DNA of the company is drawn from its founder and his vision to establish world’s only and largest producer of Clofazimine. In fact, it is this spirit of entrepreneurship that has shaped the company to become what it is today.
“The vision of a research chemist takes on social and commercial expressions that’s in a nutshell, briefly explains the genesis and growth of Sangrose labs”.
Mr. CK Alexander the founder and managing director was born and brought up in the traditions of Kerala. After acquiring his M Sc in chemistry he joined a pharmaceutical company and he started his career as a chemist. Sheer dint of hard work and determination enabled him to achieve the top management positions in various pharmaceutical majors.
After acquiring more than 30 years of experience his attachment to his motherland brought him back to his own land to contribute towards kerala’s people and economy.
His vast experience blended with entrepreneurial skill triggered him to start a company like this.
He started production of Clofazimine in the year 1989 with an initial capacity of one tonne /annum. After that there was no looking back. The company attained enhanced production capacity up to 18 tons per annum.

The Management
The management of Sangrose has personnel’s who are Qualified and possess vast knowledge and cultural experience in pharma industry. At Sangrose the experience of its distinguished board of directors, their superior knowledge and collective experience contributes to the key management team
It is this intellectual capital that drives Sangrose towards its strategic goals. The management is responsible for formulating the company’s growth strategies, innovative and entrepreneurial responsibilities for building Sangrose to its current position.
The management also determines strategic business and set up global benchmarks.
Similarly experienced professionals steer crucial operational aspects like marketing, accounts, and finance together with engineering and other operational areas.


Our Vision & Values
Dedication towards Quality:
Sangrose is dedicated to achieve the highest level of quality in all things done here.
Environment for Individual:
At Sangrose the self-esteem and dignity of an individual is upheld, we also provide an open cultured environment for expression of views and ideas.
Innovation:
We create an environment suitable for individuals to bring out the skills to innovate which in turn help one to excel and a will to experiment
Teamwork:
At Sangrose we create a better sense of teamwork the ability to work together, ability to direct individual accomplishment towards organizational objective.



Business
Tie ups is the mantra to success in this age of globalization “East meets west” as transnational companies reach out for synergistic partners to enhance their competitiveness in the global market. Companies seek partners who have state of the art R&D, manufacturing facilities with excellent customer care
Sangrose carters to all, because we believe in value added support. We are seeking partnership with pharma companies around the world by offering our facilities for contract manufacturing of API and drug intermediates. Our group ethos is based on achieving excellence in bringing out therapeutically active products


Safety & Health
At Sangrose, the safety, health and physical well being of people represent important criteria. It guarantees an environment in which our intellectual capital is adequately protected at all times, serving as an inducement for others to join.
This safety aspect has been captured in the incidence and frequency rates comprising a part of the Safety, Health and Environment report. As a forward-looking organization, we are also encouraging the reporting of near misses with a view to eliminate the root causes of accidents, representing the base of our safety pyramid.
We have also implemented an internal guideline for contractor safety, a training manual for contract workers covering job safety, tool inspection and other initiatives.


Social Initiatives
While every business comes into existence with the objective of maximizing profits and creating more sustainable value, it is also necessary to see how the community at large can benefit from its existence. Social responsibility is a commitment that has to do an important role in the overall corporate strategy of any organization.
In recognition of the conviction that the prosperity of communities is integral to the success of companies at Sangrose, we take pride in the fact that our products and what they are intended to achieve represent the core of Social Initiatives – to help people lead healthier lives. The company achieves this objective through increased access and affordability of its generics, API and branded generics products.


Concern for Environment
At Sangrose, the management of the environment is not an appendage to its business; it is integral to it.
Sangrose does not forget its social commitment a significant part of its total capital outlay is for environmental protection
This commitment to the environment goes beyond statutory requirements for an important reason: at the company we have consistently believed that environment protection and enrichment are not just preferred responses because the ecological fabric of our world is now more fragile than ever, but because this is man’s basic responsibility and its protection is the right way to do business.
A continuous monitoring system has been set up to ensure that no harm is done to the environment. Sangrose has created a green belt around the factory for total environmental protection
Environmental performance is measured across a number of parameters, some of them being:
» Water Usage
» Energy Usage
» Wastewater Discharge
» COD & TDS Load Discharge
» Hazardous & non-hazardous waste disposal
» Green house gas emissions
» Rain water harvesting and
» Effluent treatment plant



Future Plans
Sangrose is determined to become one of the leading manufacturers of some of the off-patented bulk drugs and manufacturers of some of the rare soft gelatin capsules in the world through strategic alliance/joint venture with major Multinationals